In a recent clinical study conducted with Flicker Glass™, results showed significant improvement in both visual acuity and stereopsis – even into older age ranges typically considered more challenging to treat. Study investigators were impressed with the remarkable levels of compliance, and patients and parents rated Flicker Glass™ highly on ease of use, comfort, and preference over traditional monocular therapies. From a quality of life perspective, reports of improved reading and sports performance supported the overall positive evaluation of this novel Flicker Glass™ experience.
Data presented at scientific meetings this year has been well received by the eye care and vision science communities, including academic researchers, private practice optometrists and vision therapists, and pediatric ophthalmologists. Ongoing clinical evaluation is in progress to further advance Flicker Glass™ binocular therapy
A recent study published in the Vision Development and Rehabilitation Journal (Volume 2, Issue 2 - July 2016), "
A Flicker Therapy for Treatment of Amblyopia - (click to read)" found that after 12 weeks of therapy, 96% of the children treated improved their best-corrected LogMAR visual acuity in the amblyopic eye (p<0.001) and over 26% improved 2 LogMar lines or more (fellow eye best-corrected LogMAR visual acuity did not change) and 89% of the children with reliable data improved global stereopsis.
Disclaimer: Please note that the products offered on our website have not been evaluated or reviewed by the United States Food and Drug Administration (FDA), unless explicitly stated otherwise. The information provided on this website is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease or medical condition. The products offered on our website are not intended to replace or substitute any advice, diagnosis, or treatment provided by a qualified healthcare professional. It is strongly encouraged that any use of our products in an effort to improve visual skills only be done so under the guidance and supervision of a qualified healthcare professional. Although we at Bernell choose to sell our products exclusively to healthcare professionals as they are our target market, we strongly advise that anyone who may come across our products on a secondary market consult with a qualified healthcare professional before using any product. Additionally, we do not offer instructions for intended use, nor make claims for healthcare professionals, in how to diagnose, treat, cure, or prevent any disease or medical condition with our products. The majority of the items offered under vision therapy or vision training categories on this site fall under the FDA's General Wellness: Policy for Low-Risk Items. For safety reasons, we do not condone the use any of our products that occlude or restrict vision in any way while participating in activities that may require unrestricted vision.
